NCT00486772View on ClinicalTrials.gov

Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Vascular Diseases

Interventions

DRUG

Sevelamer (Renagel), calcium acetate (Phos-ex)

All Listed Sponsors

lead

Gulhane School of Medicine

OTHER

NCT00486772 - Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD | Biotech Hunter | Biotech Hunter